Viral vectors having reduced virulence
US6750043B2 · kind B2 · utility
17Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2001 |
| Grant date | Jun 15, 2004 |
| Priority date | — |
| Expiry date | Apr 19, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24161
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA. Compositions comprising the recombinant vaccinia virus and methods of use thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.